国际生殖健康/计划生育杂志
國際生殖健康/計劃生育雜誌
국제생식건강/계화생육잡지
JOURNLA OF INTERNATIONAL REPRODUCTIVE HEALTH/FAMILY PLANNING
2014年
3期
157-161,210
,共6页
芯片分析技术%微阵列分析%生殖技术,辅助%基因组%杂交,遗传%产前诊断%微缺失微重复综合征
芯片分析技術%微陣列分析%生殖技術,輔助%基因組%雜交,遺傳%產前診斷%微缺失微重複綜閤徵
심편분석기술%미진렬분석%생식기술,보조%기인조%잡교,유전%산전진단%미결실미중복종합정
Microchip analytical procedures%Microarray analysis%Reproductive techniques,assisted%Genome%Hybridization,genetic%Prenatal diagnosis%Microdeletion and microduplication syndrome
染色体微阵列芯片分析(CMA)包括比较基因组杂交微阵列(array CGH)和单核苷酸多态微阵列(SNP array),可以在全基因组范围内高分辨检测染色体的微缺失和微重复,与传统染色体核型分析和荧光原位杂交(FISH)检测相比,具有高通量、高分辨率和高自动化检测的优势,同时可以一次性同步检测许多与出生缺陷和先天性疾病相关的基因组异常,近年来已经开始应用于侵入性产前诊断。回顾近年来多个大样本和多中心的临床试验对CMA技术用于产前诊断的研究结果,借鉴美国妇产科医师协会(ACOG)和母婴医学协会(SMFM)发布的CMA在产前诊断应用中的建议,对CMA在应用过程中如何选择微阵列芯片类型、检测的适用对象和检测的时期、检测结果的解释以及相关的遗传咨询等关键问题进行了详细讨论,并指出CMA在产前诊断应用中面临的机遇和挑战,以及检测前和检测后遗传咨询在实际应用中的重要性和必要性。
染色體微陣列芯片分析(CMA)包括比較基因組雜交微陣列(array CGH)和單覈苷痠多態微陣列(SNP array),可以在全基因組範圍內高分辨檢測染色體的微缺失和微重複,與傳統染色體覈型分析和熒光原位雜交(FISH)檢測相比,具有高通量、高分辨率和高自動化檢測的優勢,同時可以一次性同步檢測許多與齣生缺陷和先天性疾病相關的基因組異常,近年來已經開始應用于侵入性產前診斷。迴顧近年來多箇大樣本和多中心的臨床試驗對CMA技術用于產前診斷的研究結果,藉鑒美國婦產科醫師協會(ACOG)和母嬰醫學協會(SMFM)髮佈的CMA在產前診斷應用中的建議,對CMA在應用過程中如何選擇微陣列芯片類型、檢測的適用對象和檢測的時期、檢測結果的解釋以及相關的遺傳咨詢等關鍵問題進行瞭詳細討論,併指齣CMA在產前診斷應用中麵臨的機遇和挑戰,以及檢測前和檢測後遺傳咨詢在實際應用中的重要性和必要性。
염색체미진렬심편분석(CMA)포괄비교기인조잡교미진렬(array CGH)화단핵감산다태미진렬(SNP array),가이재전기인조범위내고분변검측염색체적미결실화미중복,여전통염색체핵형분석화형광원위잡교(FISH)검측상비,구유고통량、고분변솔화고자동화검측적우세,동시가이일차성동보검측허다여출생결함화선천성질병상관적기인조이상,근년래이경개시응용우침입성산전진단。회고근년래다개대양본화다중심적림상시험대CMA기술용우산전진단적연구결과,차감미국부산과의사협회(ACOG)화모영의학협회(SMFM)발포적CMA재산전진단응용중적건의,대CMA재응용과정중여하선택미진렬심편류형、검측적괄용대상화검측적시기、검측결과적해석이급상관적유전자순등관건문제진행료상세토론,병지출CMA재산전진단응용중면림적궤우화도전,이급검측전화검측후유전자순재실제응용중적중요성화필요성。
Chromosome microarray analysis(CMA), including array CGH and SNP array, was used in the invasive prenatal diagnosis of chorionic villus or amniocentesis samples to detect microdeletion and microduplica-tion in the whole genome. Compared with the conventional karyotyping and FISH methods, CMA with advantages of high throughput, high resolution and high automation can detect synchronously many abnormalities in genome related to birth defects and congenital diseases. This review summarized the recent large multicenter prospective studies about use of CMA in prenatal diagnosis, and recommendations from the American College of Obstetri-cians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine(SMFM). Some essential issues were addressed, such as the microarray type, the appropriate women for testing, sampling and the detection window, the data analysis and interpretation in genetic counseling. In addition, the opportunity and challenge during ap-plication of CMA in prenatal diagnosis were carefully discussed, and the significance and necessity of the genetic counseling in pretest and posttest were also emphasized.